Quick Links

Accreditation/Credit Designation

Physicians’ Education Resource®, LLC, is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Physicians’ Education Resource®, LLC, designates this enduring material for a maximum of 1 AMA PRA Category 1 Credit. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Physicians' Education Resource®, LLC, is approved by the California Board of Registered Nursing, Provider #16669, for 1.0 Contact Hours.

Acknowledgment of Commercial Support

This activity is supported by an educational grant from Bristol-Myers Squibb.

Oncology Briefings™: Harnessing the Predictive Powers of Biomarkers in Immuno-Oncology

Release Date: July 31, 2018
Expiration Date: July 31, 2019
Media: Internet - based

Activity Overview

This activity, Oncology Briefings™: Harnessing the Predictive Powers of Biomarkers in Immuno-Oncology, developed in Physicians’ Education Resource, LLC, (PER®) established Oncology Briefings™ legacy format, is an online interactive monograph that provides an overview of the current and future role of biomarkers in predicting pan-tumor response to immunotherapy in cancer. This presentation features a national thought leader, Hossein Borghaei, DO, MS, who provides key insights.

Acknowledgment of Commercial Support

This activity is supported by an educational grant from Bristol-Myers Squibb.

Instructions for This Activity and Receiving Credit

  • You will need to login to participate in the activity.
  • Each presentation may contain an interactive question(s). You may move forward through the presentation; however, you may not go back to change answers or review videos/content until you finish the presentation.
  • At the end of the activity, “educational content/video files” will be available for your reference.
  • In order to receive a CME/CE certificate, participants must complete the activity.
  • Complete the posttest and pass with a score of 70% or higher, complete the evaluation and then click on request for credit. Participants may immediately download a CME/CE certificate upon completion of these steps.

Target Audience

This educational initiative is directed toward medical oncologists, oncology pathologists, clinical/biomedical researchers, hematologists, pathologists, and other healthcare professionals interested in personalized medicine and biomarker research. Nurse practitioners, nurses, physician assistants, pharmacists, fellows, and other healthcare professionals are also invited to participate.

Educational Objectives

Upon completion of this activity, participants should be better prepared to:

  • Define next-generation sequencing (NGS) and comprehensive gene panels, and its utility in identifying potential biomarkers and response to cancer immunotherapeutics
  • Explain the potential utility of NGS in characterizing the tumor microenvironment
  • Synthesize and integrate clinical study data illustrating the appropriate use of NGS in immuno-oncology across multiple tumor types
  • Identify current NGS technology platforms and comprehensive gene panels and their advantages and disadvantages

Faculty, Staff, and Planners' Disclosure

Hossein Borghaei, DO, MS
Chief, Division of Thoracic Medical Oncology
Associate Professor, Department of Hematology/Oncology
Co-Director, Immune Monitoring Facility
Lung Cancer and Mesothelioma TRDG Member
Fox Chase Cancer Center
Temple Health
Philadelphia, PA

Disclosure: Grant/Research Support: Millennium, Merck, Celgene, Lilly, BMS; Consultant: BMS, Lilly, Genentech, Pfizer, Merck, AstraZeneca, Genmab, Celgene, EMD Serono, Boehringer Ingelheim, Regeneron, BioNTech, Cantargia AB

The staff of Physicians' Education Resource®, LLC have no relevant financial relationships with commercial interests to disclose.

Disclosure Policy and Resolution of Conflicts of Interest

As a sponsor accredited by the ACCME, it is the policy of PER® to ensure fair balance, independence, objectivity, and scientific rigor in all of its CME activities. In compliance with ACCME guidelines, PER® requires everyone who is in a position to control the content of a CME activity to disclose all relevant financial relationships with commercial interests. The ACCME defines “relevant financial relationships” as financial relationships in any amount occurring within the past 12 months that creates a COI.
Additionally, PER® is required by ACCME to resolve all COI. PER® has identified and resolved all COI prior to the start of this activity by using a multistep process.

Off-Label Disclosure and Disclaimer

This CME activity may or may not discuss investigational, unapproved, or off-label use of drugs. Participants are advised to consult prescribing information for any products discussed. The information provided in this CME activity is for continuing medical and nursing education only, and is not meant to substitute for the independent clinical judgment of a physician relative to diagnostic, treatment, or management options for a specific patient’s medical condition. The opinions expressed in the content are solely those of the individual faculty member, and do not reflect those of PER® or the company that provided commercial support for this activity.

Become a Member

Forgot Password?
Calendar of Events
Filter By